BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12786697)

  • 1. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma.
    Kokoszka A; Scheinfeld N
    Dermatol Surg; 2003 Jun; 29(6):566-71. PubMed ID: 12786697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basal cell carcinoma of the nose].
    Bonvallot T; Raulo Y; Zeller J; Faivre JM; Horn G; Baruch J
    Ann Dermatol Venereol; 1993; 120(3):209-14. PubMed ID: 8239358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma.
    Kuijpers DI; Thissen MR; Berretty PJ; Ideler FH; Nelemans PJ; Neumann MH
    Dermatol Surg; 2007 May; 33(5):579-87. PubMed ID: 17451581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cryosurgery for nose basal cell carcinoma. Series of 17 tumors].
    Zribi H; Cherif F; Zakraoui H; Cheikhrouhou R; Mokni M; Ben Osman Dhahri A
    Tunis Med; 2006 Aug; 84(8):473-6. PubMed ID: 17175686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules.
    Mallon E; Dawber R
    Dermatol Surg; 1996 Oct; 22(10):854-8. PubMed ID: 9246168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical treatment of basal cell carcinoma].
    Helsing P; Kramer P; Haugstvedt A; Aarebrot S; Todal A; Moseng D; Loeb M
    Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2740-2. PubMed ID: 15534663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
    Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
    Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year results of curettage-cryosurgery of selected large primary basal cell carcinomas on the nose: an alternative treatment in a geographical area underserved by Mohs' surgery.
    Nordin P; Larkö O; Stenquist B
    Br J Dermatol; 1997 Feb; 136(2):180-3. PubMed ID: 9068728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective follow-up after curettage-cryosurgery for scalp and face skin cancers.
    Lindemalm-Lundstam B; Dalenbäck J
    Br J Dermatol; 2009 Sep; 161(3):568-76. PubMed ID: 19624544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure.
    Morris DS; Elzaridi E; Clarke L; Dickinson AJ; Lawrence CM
    Br J Ophthalmol; 2009 Apr; 93(4):474-6. PubMed ID: 19060015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Earlier detection of patients' second primary basal cell carcinomas: a quantitative analysis.
    Allen SB; Lortscher DN; Sengelmann RD
    Dermatol Surg; 2007 Jan; 33(1):69-72. PubMed ID: 17214681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of Mohs micrographic surgery: review of the literature.
    Tierney EP; Hanke CW
    J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cryosurgery of basal cell carcinoma: a study of 358 patients].
    Bernardeau K; Derancourt C; Cambie M; Salmon-Ehr V; Morel M; Cavenelle F; Léonard F; Kalis B; Bernard P
    Ann Dermatol Venereol; 2000 Feb; 127(2):175-9. PubMed ID: 10739976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
    Lawrence CM; Haniffa M; Dahl MG
    Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
    Essers BA; Dirksen CD; Nieman FH; Smeets NW; Krekels GA; Prins MH; Neumann HA
    Arch Dermatol; 2006 Feb; 142(2):187-94. PubMed ID: 16490846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of the cryosurgery in the management of xeroderma pigmentosum].
    Zghal M; Triki S; Elloumi-Jellouli A; Jbali A; Gargouri H; Benmously R; Souissi R; Chedly I; Brahim EB; Ayed MB; Fenniche S; Mokhtar I
    Ann Dermatol Venereol; 2010 Oct; 137(10):605-9. PubMed ID: 20932439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.